Heinz Burgmann - Infectious Diseases

Author Information

Heinz Burgmann is affiliated with the Clinical Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, at the Medical University of Vienna, located in Vienna, Austria. His work primarily revolves around infectious diseases, with significant contributions to understanding various aspects of infectious pathogens, immunological responses, and treatment strategies.

Research Contributions

Heinz Burgmann has made substantial contributions to the field of infectious diseases, as evident from his extensive research on topics such as the immunogenicity of COVID-19 vaccinations, responses to SARS-CoV-2 vaccination in patients with autoimmune diseases, and innovative surveillance methods like wastewater-based epidemiology for antibiotic resistance. His research also extends to pharmacokinetics of antibiotics and the study of bacterial etiology in community-acquired pneumonia.

Aliases

Heinz Burgmann is also known by other aliases including H Burgmann and H. Burgmann. These variations are used interchangeably in his publications and academic references.

Publication and Citation Metrics

Metric	Value
Citation Count	4877
h-index	36
Paper Count	239

Publications:

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

DOI: 10.3390/cancers14081962

Year: 2022

Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic Echinococcosis

DOI: 10.3390/pathogens11020261

Year: 2022

Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study

DOI: 10.1136/annrheumdis-2021-221788

Year: 2022

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model

DOI: 10.3389/fphar.2021.702455

Year: 2021

Wastewater Based Epidemiology Enabled Surveillance of Antibiotic Resistance

DOI: 10.1101/2021.06.01.21258164

Year: 2021

A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence

DOI: 10.3390/ijerph18084201

Year: 2021

Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model

DOI: 10.3389/fphar.2021.685807

Year: 2021

Extracellular vesicles and citrullinated histone H 3 in coronavirus disease 2019 (COVID-19) patients.

DOI: 10.1055/a-1522-4131

Year: 2021

Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels.

DOI: 10.1093/jac/dkab286

Year: 2021

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade

DOI: 10.1007/s15010-021-01605-w

Year: 2021

What are Muscle Aches?

What is the Current Research Focus?

Why is PCR Important in Infectious Diseases?

What are the Advantages of HTS in Infectious Disease Research?

Are There Alternatives to Traditional Antibiotics?

How Can We Prevent the Spread of Aedes Albopictus?

How Can Food and Water Contamination be Prevented?

What Are the Side Effects of Antimalarial Drugs?

Why are Surveillance Systems Important?

How Can Hygiene Practices be Implemented in Healthcare Settings?

Partnered Content Networks

Relevant Topics